Navigation Links
Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend
Date:10/23/2007

ST. LOUIS, Oct. 23 /PRNewswire-FirstCall/ -- Young Innovations, Inc. (Nasdaq: YDNT) today announced results for the quarter and nine months ended September 30, 2007.

Sales for the third quarter were $24.7 million, increasing 3.5% over the $23.8 million reported for the third quarter of 2006. Income from operations decreased 16.8% to $5.2 million from $6.2 million in the prior year. Net income of $3.1 million decreased 22.1% from $3.9 million in the prior year. Diluted earnings per share for the third quarter of 2007 were $0.35, a decrease of 18.6% over the $0.43 reported in the prior year quarter. For the quarter ended September 30, 2007, diluted shares outstanding were 8,773,000 a decrease of 410,000 shares over the prior year, principally reflecting the pro rata impact of the 1 million share repurchase completed on August 15, 2007. Diluted earnings per share were affected by equity compensation expense of $0.02 and $0.01 for the quarters ended September 30, 2007 and 2006, respectively.

For the nine months ended September 30, 2007, sales were $72.4 million, increasing 9.7% from the prior year period. Income from operations for the nine months ended September 30, 2007 decreased 9.4% to $15.7 million from $17.3 million in the prior year. Net income was $9.4 million, decreasing 15.5% from $11.1 million in the year earlier nine-month period. Diluted earnings per share were $1.03 for the nine months ended September 30, 2007, a decrease of 14.9% from $1.21 in the same period of 2006. For the nine months ended September 30, 2007, diluted shares outstanding were 9,082,000 a decrease of 96,000 shares over the prior year, principally reflecting the pro rata impact of the 1 million share repurchase completed on Augu
'/>"/>

SOURCE Young Innovations, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Young womens woes
2. Young womens woes
3. Eat Vitamin C and stay young
4. Viagra Used More By Young Men
5. Movies Influence Youngsters To Drink
6. Stay young the Chinese way
7. Have sex and stay young
8. Bronchitis in the young
9. Zinc may enhance growth in Young sickle cell patients
10. Smoke less to stay young
11. Young women prone to heart attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Pools and beaches are the place to be on hot ... small children, so Amica Insurance is sharing five ... for Disease Control and Prevention, children between the ages of ... and deaths. It’s important to know the best practices for ... the following tips from the American Red Cross:, ...
(Date:7/24/2014)... 2014 (HealthDay News) -- Drinking caffeine may worsen the ... of women as they go through menopause, new survey ... study suggests that limiting caffeine intake may be useful ... and night sweats," said researcher Dr. Stephanie Faubion, director ... in Rochester, Minn. But caffeine -- a stimulant ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 Horizon ... will give one lucky family a rent-free week in ... until August 3, 2014. Don’t miss your chance to ... sweepstakes is open to all New Jersey residents, 25 ... BCBSNJ Facebook page, http://www.facebook.com/HorizonBCBSNJ . , “A ...
(Date:7/24/2014)... working with high-throughput data generated by breast cancer ... a computational method to determine how gene networks ... and as they respond to potential cancer therapy ... with each other in laboratory-grown cells is described ... journal PLOS Computational Biology . , The ...
(Date:7/24/2014)... the Human Papillomavirus Vaccination (HPV) even after becoming ... test results than those who were never vaccinated. ... Transmitted Diseases . , Researchers from Boston ... Medicine conducted a cross-sectional study of 235 women ... testing. HPV status and demographic and behavioral characteristics ...
Breaking Medicine News(10 mins):Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... Yale School of Medicine has revealed that diet soda ... recently it was believed that there was a 350% ... soft drinks. In their study published in the recent ... researchers report that the link is unfounded, and warn ...
... due to the use of mobile phones, nor do mobile ... belonging to the Essex University//. The research was headed by ... and asked them to do several memory tests. Participants were ... ,Contrary to previous studies that had claimed that ...
... might reduce the risk of colon cancer have been slashed ... of statins// for cardiovascular disease of 87,000 participants were analyzed ... variety of other cancers in people who took the drugs ... other also had similar results and found no reduced incidence ...
... Bird flu scare in Australia was reported after a man was admitted ... collapsed in the flight// from Taipei and the air port authorities removed ... hospital after he complained of feeling tired and not keeping well. ... is kept in the hospital in total isolation. ,The hospital ...
... used for reducing the cardiovascular risk by lowering the ... it has anti-cancer benefits. Two individual studies by Professor ... Professor Eric Jacobs, American Cancer Society have found that ... disagreed with some researchers reporting the anti-cancer effects of ...
... in 2006 and 2007 on HIV prevention, nearly double the ... to a report published by the // China ... League's Central Committee, the government spent about $12.3 million on ... 2003 and 2004. The government has created short-term and long-term ...
Cached Medicine News:Health News:Soft Drinks May Reduce Esophageal Cancer Risk 2Health News:Counter study: cholesterol drugs no good in preventing colon cancer 2
(Date:7/24/2014)... BUFFALO, N.Y. , July 24, 2014  Kinex ... US FDA for the Company,s KX2-391 Ointment for the ... keratosis. This is the Company,s third IND to be ... months. KX2-391 is a synthetic, orally active ... and tubulin polymerization. KX2-391 promotes the induction of p53, ...
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Monitoring Market by Product, Component, Application and Geography - ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... expected to witness a moderate growth as the markets ... have almost reached the saturation levels. The demand is ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... Nov. 7, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: ... 30, 2011. Total revenue was $2.6 million and $8.2 ... compared to $1.3 million and $3.8 million for the same periods ... nine months ended September 30, 2011, were $9.0 million and $24.0 ...
... CHICAGO, Nov. 7, 2011 UCB today announced findings ... rates to Cimzia ® (certolizumab pegol) plus methotrexate ... effect on structural joint damage in patients with moderate ... responses were found by both RAPID3 (Routine Assessment of ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 9New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 2New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 3New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 4New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 5New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 6New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 7New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 8New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 9New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 10New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 11New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 12
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
... for cystometry and urethral pressure profilometry. ... faster filling of the bladder and ... lumen catheter construction allows the bladder ... performed. Triple lumen catheter construction allows ...
... with AMI symptoms and time is ... rapid, reliable and accurate solution for ... enhancement techniques, state-of-the-art fluorescence analysis, and ... delivers highly sensitive results without compromising ...
... Capillary Blood Collection Tubes are 100% plastic ... wide range of applications, the Capillary Collection ... attached cap and a micro tube.,The capillary ... blood into the micro tube thereby eliminating ...
Medicine Products: